Sodium Chloride 70mg/ml, Sodium Hyaluronate 1mg/ml (Hyaneb®)

Assessment Status Rapid review complete
HTA ID -
Drug Sodium Chloride 70mg/ml, Sodium Hyaluronate 1mg/ml
Brand Hyaneb®
Indication  Is particularly indicated in patients with cystic fibrosis and in patients with bronchiectasis.  Hyaneb® is classified as a medical device and carries a CE mark.
Assessment Process
Rapid review commissioned 10/02/2014
Rapid review completed 19/03/2014
Rapid review outcome Full Pharmacoeconomic Evaluation not recommended